למיקטל טבליות מסיסות/לעיסות 50 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

LAMOTRIGINE 50 MG

Disponible depuis:

GLAXO SMITH KLINE (ISRAEL) LTD

Code ATC:

N03AX09

forme pharmaceutique:

DISPERSIBLE/CHEWABLE TABLETS

Mode d'administration:

PER OS

Fabriqué par:

GLAXO WELLCOME OPERATIONS LTD, UK

Groupe thérapeutique:

LAMOTRIGINE

indications thérapeutiques:

Epilepsy: Monotherapy in adults and children over 12 years of age: 1. Simple partial seizures. 2. complex partial seizures. 3. generalised tonic clonic secondarily seizures. 4. Primary generalised tonic clonic seizures. Add-on therapy in adults and children over 2 years of age: 1. Simple partial seizures. 2. Complex partial seizures. 3. Secondarily generalised tonic clonic seizures. Adults (18 years of age and over) Lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

Date de l'autorisation:

2008-11-01